Gottlieb: FDA To Focus On Communicating Opioid Dosing, Potency

FDA wants to help health care providers better understand the different levels of potency across opioid medications, FDA Commissioner Scott Gottlieb said Thursday (Oct. 18). The agency plans to increase its focus on communicating morphine equivalents and how to convert milligram strengths for various opioids, as doing so could help curb the number of patients who are prescribed high doses of opioids at the outset. During a Politico event on Thursday, Gottlieb highlighted FDA's upcoming plans to exercise its newly...